Physician profile
Kunwar Khalsa
NPI 1417377201
$182,292.85
in general payments reported to CMS, 2019-2025
25 companies · $63K in 2025
The $63K reported for 2025 was more than what 89% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $3,604 · 2021: $18K · 2022: $19K · 2023: $36K · 2024: $43K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $11K · Food and Beverage: $2,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $104,762.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,325.00 |
| Travel and Lodging | $11,215.07 |
| Food and Beverage | $2,790.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $155,685.43 | 2021-2025 | Tlif, Elsa, Elsa Al/Atp, Excelsius Gps |
| Arteriocyte Medical Systems, INC. | $11,618.49 | 2019-2024 | Magellan |
| Cerapedics INC. | $7,589.43 | 2020-2024 | I-Factor Peptide Enhanced Bone Graft |
| Medical Device Business Services, INC. | $1,721.39 | 2020 | |
| Alphatec Spine, INC | $1,594.43 | 2021 | |
| Biotronik Nro, INC. | $1,158.54 | 2024-2025 | Prospera |
| Abbott Laboratories | $833.00 | 2022-2025 | Penta, Octrode, Proclaim |
| Nalu Medical, INC. | $407.94 | 2021-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $353.47 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $278.62 | 2019-2021 | |
| Cardiovascular Systems INC. | $142.10 | 2023 | Diamondback Peripheral |
| Smith+Nephew, INC. | $131.41 | 2020 | |
| Carlsmed, INC. | $125.97 | 2022 | |
| Orthofix Medical, INC. | $122.40 | 2020-2023 | Spinal-Stim, Spinal-Stim |
| Seaspine Orthopedics Corporation | $111.99 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xtant Medical INC | $92.74 | 2025 | |
| Providence Medical Technology, INC. | $71.30 | 2022-2023 | |
| Lenoss Medical INC | $59.63 | 2024 | Access & Cavity Creation Kit |
| Depuy Synthes Sales INC. | $50.14 | 2020 | |
| Medtronic, INC. | $40.86 | 2021 | |
| Stryker Corporation | $33.94 | 2020 | |
| Ethicon US, LLC | $22.66 | 2020 | |
| Si-Bone, INC. | $19.93 | 2019 | |
| Zimvie INC. | $18.63 | 2022 | |
| Electronic Waveform Lab, INC. | $8.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunwar Khalsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.